ABVC
Price
$0.74
Change
-$0.17 (-18.68%)
Updated
Apr 4, 04:59 PM (EDT)
Capitalization
26.18M
AMGXF
Price
$0.36
Change
-$0.05 (-12.20%)
Updated
Dec 5 closing price
Capitalization
139.75M
Ad is loading...

ABVC vs AMGXF

Header iconABVC vs AMGXF Comparison
Open Charts ABVC vs AMGXFBanner chart's image
ABVC BioPharma
Price$0.74
Change-$0.17 (-18.68%)
Volume$500
Capitalization26.18M
AnGes MG
Price$0.36
Change-$0.05 (-12.20%)
Volume$2.05K
Capitalization139.75M
ABVC vs AMGXF Comparison Chart
Loading...
ABVC
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
ABVC vs. AMGXF commentary
Apr 05, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ABVC is a Hold and AMGXF is a Hold.

Ad is loading...
COMPARISON
Comparison
Apr 05, 2025
Stock price -- (ABVC: $0.91 vs. AMGXF: $0.36)
Brand notoriety: ABVC and AMGXF are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: ABVC: 72% vs. AMGXF: 100%
Market capitalization -- ABVC: $26.18M vs. AMGXF: $139.75M
ABVC [@Biotechnology] is valued at $26.18M. AMGXF’s [@Biotechnology] market capitalization is $139.75M. The market cap for tickers in the [@Biotechnology] industry ranges from $299.64B to $0. The average market capitalization across the [@Biotechnology] industry is $2.17B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

ABVC’s FA Score shows that 0 FA rating(s) are green whileAMGXF’s FA Score has 0 green FA rating(s).

  • ABVC’s FA Score: 0 green, 5 red.
  • AMGXF’s FA Score: 0 green, 5 red.
According to our system of comparison, ABVC is a better buy in the long-term than AMGXF.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

ABVC’s TA Score shows that 3 TA indicator(s) are bullish.

  • ABVC’s TA Score: 3 bullish, 4 bearish.

Price Growth

ABVC (@Biotechnology) experienced а +14.46% price change this week, while AMGXF (@Biotechnology) price change was 0.00% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was -10.73%. For the same industry, the average monthly price growth was -16.65%, and the average quarterly price growth was -18.36%.

Reported Earning Dates

ABVC is expected to report earnings on Nov 13, 2023.

Industries' Descriptions

@Biotechnology (-10.73% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
AMGXF($140M) has a higher market cap than ABVC($26.2M). ABVC YTD gains are higher at: 55.000 vs. AMGXF (0.000). ABVC has higher annual earnings (EBITDA): -6.36M vs. AMGXF (-7.81B). AMGXF has more cash in the bank: 1.82B vs. ABVC (208K). ABVC has less debt than AMGXF: ABVC (2.33M) vs AMGXF (336M). AMGXF has higher revenues than ABVC: AMGXF (449M) vs ABVC (510K).
ABVCAMGXFABVC / AMGXF
Capitalization26.2M140M19%
EBITDA-6.36M-7.81B0%
Gain YTD55.0000.000-
P/E RatioN/AN/A-
Revenue510K449M0%
Total Cash208K1.82B0%
Total Debt2.33M336M1%
FUNDAMENTALS RATINGS
ABVC vs AMGXF: Fundamental Ratings
ABVC
AMGXF
OUTLOOK RATING
1..100
2335
VALUATION
overvalued / fair valued / undervalued
1..100
47
Fair valued
67
Overvalued
PROFIT vs RISK RATING
1..100
100100
SMR RATING
1..100
9895
PRICE GROWTH RATING
1..100
3575
P/E GROWTH RATING
1..100
100100
SEASONALITY SCORE
1..100
5030

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

ABVC's Valuation (47) in the null industry is in the same range as AMGXF (67). This means that ABVC’s stock grew similarly to AMGXF’s over the last 12 months.

ABVC's Profit vs Risk Rating (100) in the null industry is in the same range as AMGXF (100). This means that ABVC’s stock grew similarly to AMGXF’s over the last 12 months.

AMGXF's SMR Rating (95) in the null industry is in the same range as ABVC (98). This means that AMGXF’s stock grew similarly to ABVC’s over the last 12 months.

ABVC's Price Growth Rating (35) in the null industry is somewhat better than the same rating for AMGXF (75). This means that ABVC’s stock grew somewhat faster than AMGXF’s over the last 12 months.

ABVC's P/E Growth Rating (100) in the null industry is in the same range as AMGXF (100). This means that ABVC’s stock grew similarly to AMGXF’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
ABVC
RSI
ODDS (%)
Bearish Trend 2 days ago
90%
Stochastic
ODDS (%)
Bearish Trend 2 days ago
90%
Momentum
ODDS (%)
Bullish Trend 2 days ago
79%
MACD
ODDS (%)
Bullish Trend 2 days ago
68%
TrendWeek
ODDS (%)
Bullish Trend 2 days ago
68%
TrendMonth
ODDS (%)
Bullish Trend 2 days ago
70%
Advances
ODDS (%)
Bullish Trend 4 days ago
76%
Declines
ODDS (%)
Bearish Trend 2 days ago
90%
BollingerBands
ODDS (%)
Bearish Trend 2 days ago
90%
Aroon
ODDS (%)
N/A
View a ticker or compare two or three
Ad is loading...
ABVC
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
GLBS1.18-0.02
-2.02%
Globus Maritime Limited
PEG81.55-2.24
-2.67%
Public Service Enterprise Group
KRC30.56-2.74
-8.23%
Kilroy Realty Corp
PFS16.01-1.59
-9.03%
Provident Financial Services
FLIC11.12-1.17
-9.52%
First of Long Island Corp

ABVC and

Correlation & Price change

A.I.dvisor indicates that over the last year, ABVC has been loosely correlated with KNSA. These tickers have moved in lockstep 40% of the time. This A.I.-generated data suggests there is some statistical probability that if ABVC jumps, then KNSA could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ABVC
1D Price
Change %
ABVC100%
-17.24%
KNSA - ABVC
40%
Loosely correlated
-0.41%
MRSN - ABVC
33%
Loosely correlated
-9.94%
MLEC - ABVC
31%
Poorly correlated
-4.18%
FULC - ABVC
27%
Poorly correlated
-9.89%
PVLA - ABVC
25%
Poorly correlated
-9.42%
More

AMGXF and

Correlation & Price change

A.I.dvisor indicates that over the last year, AMGXF has been loosely correlated with PRTG. These tickers have moved in lockstep 34% of the time. This A.I.-generated data suggests there is some statistical probability that if AMGXF jumps, then PRTG could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To AMGXF
1D Price
Change %
AMGXF100%
N/A
PRTG - AMGXF
34%
Loosely correlated
-13.61%
APLT - AMGXF
33%
Loosely correlated
-7.01%
TLSA - AMGXF
21%
Poorly correlated
-8.11%
SCNI - AMGXF
21%
Poorly correlated
-4.91%
ABVC - AMGXF
3%
Poorly correlated
-17.24%
More